Design, synthesis, and biological evaluation of a series of novel cordycepin derivatives

doi:10.5246/jcps.2022.01.006

Abstract

Abstract:

: In this study, a novel series of cordycepin derivatives with benzenesulfonamido groups at the 6-position of the purine ring were synthesized and their antitumor activity was evaluated. We revealed the structural moieties of the cordycepin analogs that were required for antitumor activity. Among all the target compounds, those with 4-methyl and 4-nitro substituents on the benzene ring displayed better activity than the lead compound in antiproliferative activity experiments using MDA-MB-231 and A549 cells. However, compounds with 4-methoxybenzene and 2-oxoindoline groups and ethylene spacers displayed more significant activity than the lead compound in antiproliferative activity experiments using HeLa cells. In particular, a compound with a 4-bromo substituent and an ethylene spacer displayed very high inhibitory activity against the proliferation of MDA-MB-231, A549, and HeLa cells, suggesting that it had the potential for further development and application.

Key words: Cordycepin, Derivatives, Synthesis, Biological activity research

Supporting:

Lijuan Jiang, Tingting Cao, Ruoyi Yang, Ying Li, Lin Dong, Shufan Yin. Design, synthesis, and biological evaluation of a series of novel cordycepin derivatives[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(1): 55-67.

Figures/Tables 4

References 21

[1]	Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clin. 2018, 68, 394–424.
[2]	Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2019. CA: A Cancer J. Clin. 2019, 69, 7–34.
[3]	Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clin. 2018, 68, 394–424.
[4]	Yu, H.M.; Wang, B.S.; Huang, S.C.; Duh, P.D. Comparison of protective effects between cultured Cordyceps militaris and natural Cordyceps sinensis against oxidative damage. J. Agric. Food Chem. 2006, 54, 3132–3138.
[5]	Tsai, Y.J.; Lin, L.C.; Tsai, T.H. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J. Agric. Food Chem. 2010, 58, 4638–4643.
[6]	Chen, Y.; Chen, Y.C.; Lin, Y.T.; Huang, S.H.; Wang, S.M. Cordycepin induces apoptosis of CGTH W-2 thyroid carcinoma cells through the Calcium-Calpain-Caspase 7-PARP pathway. J. Agric. Food Chem. 2010, 58, 11645–11652.
[7]	Aman, S.; Anderson, D.J.; Connolly, T.J.; Crittall, A.J.; Ji, G.J. From adenosine to 3’-deoxyadenosine: development and scale up. Org. Process. Res. Dev. 2000, 4, 601–605.
[8]	Vodnala, S.K.; Lundbäck, T.; Yeheskieli, E.; Sjöberg, B.; Gustavsson, A.L.; Svensson, R.; Olivera, G.C.; Eze, A.A.; de Koning, H.P.; Hammarström, L.G.J.; Rottenberg, M.E. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis. J. Med. Chem. 2013, 56, 9861–9873.
[9]	Vodnala, S.K.; Lundbäck, T.; Yeheskieli, E.; Sjöberg, B.; Gustavsson, A.L.; Svensson, R.; Olivera, G.C.; Eze, A.A.; de Koning, H.P.; Hammarström, L.G.J.; Rottenberg, M.E. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis. J. Med. Chem. 2013, 56, 9861–9873.
[10]	Bouchain, G.; Leit, S.; Frechette, S.; Khalil, E.A.; Lavoie, R.; Moradei, O.; Woo, S.H.; Fournel, M.; Yan, P.T.; Kalita, A.; Trachy-Bourget, M.C.; Beaulieu, C.; Li, Z.M.; Robert, M.F.; MacLeod, A.R.; Besterman, J.M.; Delorme, D. Development of potential antitumor agents. synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors. J. Med. Chem. 2003, 46, 820–830.
[11]	Morimoto, H.; Shimadzu, H.; Kushiyama, E.; Kawanishi, H.; Hosaka, T.; Kawase, Y.; Yasuda, K.; Kikkawa, K.; Yamauchi-Kohno, R.; Yamada, K. Potent and Selective ET-A Antagonists. 1. Syntheses and Structure–Activity Relationships of N-(6-(2-(Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives. J. Med. Chem. 2001, 44, 3355–3368.
[12]	Noreljaleel, A.E.M.; Wilhelm, A.; Bonnet, S.L.; van der Westhuizen, J.H. Synthesis and bioactivity of reduced chalcones containing sulfonamide side chains. J. Nat. Prod. 2018, 81, 41–48.
[13]	Sato, K.; Takahagi, H.; Yoshikawa, T.; Morimoto, S.; Takai, T.; Hidaka, K.; Kamaura, M.; Kubo, O.; Adachi, R.; Ishii, T.; Maki, T.; Mochida, T.; Takekawa, S.; Nakakariya, M.; Amano, N.; Kitazaki, T. Discovery of a novel series of N-phenylindoline-5-sulfonamide derivatives as potent, selective, and orally bioavailable acyl CoA: monoacylglycerol acyltransferase-2 inhibitors. J. Med. Chem. 2015, 58, 3892–3909.
[14]	Yang, P.; Wang, L.P.; Feng, R.T.; Almehizia, A.A.; Tong, Q.; Myint, K.Z.; Ouyang, Q.; Alqarni, M.H.; Wang, L.R.; Xie, X.Q. Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation. J. Med. Chem. 2013, 56, 2045–2058.
[15]	Tsai, Y.J.; Lin, L.C.; Tsai, T.H. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J. Agric. Food Chem. 2010, 58, 4638–4643.
[16]	Bi, Y.M.; Li, H.; Yi, D.Z.; Sun, Y.X.; Bai, Y.; Zhong, S.; Song, Y.; Zhao, G.; Chen, Y. Cordycepin augments the chemosensitivity of human glioma cells to temozolomide by activating AMPK and inhibiting the AKT signaling pathway. Mol. Pharm. 2018, 15, 4912–4925.
[17]	Wen, Z.X.; Du, X.F.; Meng, N.; Li, Y.J.; Mi, R.; Li, X.J.; Sun, Y.X.; Ma, S.H.; Li, S.Y. Tussah silkmoth pupae improve anti-tumor properties of Cordyceps militaris (L.) Link by increasing the levels of major metabolite cordycepin. RSC Adv. 2019, 9, 5480–5491.
[18]	Khuntawee, W.; Amornloetwattana, R.; Vongsangnak, W.; Namdee, K.; Yata, T.; Karttunen, M.; Wong-Ekkabut, J. In silico and in vitro design of cordycepin encapsulation in liposomes for colon cancer treatment. RSC Adv. 2021, 11, 8475–8484.
[19]	Singpoonga, N.; Rittiron, R.; Seang-On, B.; Chaiprasart, P.; Bantadjan, Y. Determination of adenosine and cordycepin concentrations in cordyceps militaris fruiting bodies using near-infrared spectroscopy. ACS Omega. 2020, 5, 27235–27244.
[20]	Guianvarc'H, D.; Duca, M.; Boukarim, C.; Kraus-Berthier, L.; Léonce, S.; Pierré, A.; Pfeiffer, B.; Renard, P.; Arimondo, P.B.; Monneret, C.; Dauzonne, D. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin. J. Med. Chem. 2004, 47, 2365–2374.
[21]	Morimoto, H.; Shimadzu, H.; Kushiyama, E.; Kawanishi, H.; Hosaka, T.; Kawase, Y.; Yasuda, K.; Kikkawa, K.; Yamauchi-Kohno, R.; Yamada, K. Potent and Selective ET-A Antagonists. 1. Syntheses and Structure–Activity Relationships of N-(6-(2-(Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives. J. Med. Chem. 2001, 44, 3355–3368.